Beijing-based endoscopic surgical robot developer, Beijing Surgerii Robotics Company Limited, has reportedly raised hundreds of millions of renminbi in a Series C3 financing round. The round was led by Loyal Valley Capital, with participation from other investors including V Star Capital, SDIC, DNV Capital, and Sunart Investment.
Investment to Drive Clinical Studies, Market Promotion, and Global Expansion
The proceeds from the financing will be allocated towards clinical studies and market promotion, new product research and development, and the global commercialization layout of Surgerii’s technology. Additionally, the funds will support cooperation with top-class hospitals, enhancing the company’s position in the medical robotics sector.
Surgerii’s Single-Hole Surgical Robot: Versatility and Application
Surgerii’s single-hole surgical robot is widely applied across various medical fields, including urology, gynecology, general surgery, thoracic surgery, and cardiac surgery. The versatility of the robot highlights its potential to revolutionize surgical procedures and improve patient outcomes in multiple specialties.-Fineline Info & Tech
